SCHEMBL14438587

SCHEMBL14438587

CCCOCCOCCOc1ccc(-c2nc3ccc(-c4nc5ccc(N6CCN(C)CC6)cc5[nH]4)cc3[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.79
▸ SMN1; SMN2 Q16637 4/20 0.79
▸ MAPT P10636 3/20 0.79
▸ MEN1 O00255 2/20 0.79
▸ BLM P54132 2/20 0.79
▸ KMT2A Q03164 2/20 0.79
▸ SLCO2B1 O94956 1/20 0.79
▸ GLA P06280 1/20 0.79
▸ RECQL P46063 1/20 0.79
▸ BCL2L1 Q07817 1/20 0.79
▸ SLCO1B3 Q9NPD5 1/20 0.79
▸ TDP1 Q9NUW8 1/20 0.79
▸ SLCO1B1 Q9Y6L6 1/20 0.79
▸ TOP1 P11387 3/20 0.70
▸ TOP2A P11388 3/20 0.70
▸ HPGD P15428 1/20 0.64
▸ HSD17B10 Q99714 1/20 0.64
▸ KDM4E B2RXH2 3/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ POLB P06746 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14453641 0.92 ALDH1A1 (0.85) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL25434497 0.90 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL38686 0.88 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL29350649 0.88 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL23424044 0.87 ALDH1A1 (0.80) ALDH1A1SMN1; SMN2MAPTMEN1BLM
Hydrochloric Acid SCHEMBL29387917 0.87 ALDH1A1 (0.98) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL23424055 0.87 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL23482780 0.86 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL24233357 0.85 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2MAPTMEN1BLM
SCHEMBL19975798 0.85 TOP1 (0.76) ALDH1A1SMN1; SMN2MAPTMEN1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070179100-A1 Protected monomers ALNYLAM PHARMACEUTICALS, INC. 2007-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179100-A1 Protected monomers PCNA, POLN, PARP1 ALDH1A1 1923/4885SMN1; SMN2 700/4885MAPT 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback